Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.
Asset management firm Grayscale applied to the US Securities and Exchange Commission (SEC) to list shares of the Grayscale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback